Mercer Global Advisors
DERM icon

Mercer Global Advisors’s Journey Medical DERM Stock Holding History

Mercer Global Advisors’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.72K Buy
+808
New +$4.61K ﹤0.01% 5309

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Mercer Global Advisors's DERM Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Journey Medical (DERM) in Q2 2026: 808 shares worth $5.72K. The stake represents ﹤0.01% of the portfolio and ranks #5309 among its holdings.

43 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Mercer Global Advisors held 808 shares of Journey Medical worth $5.72K as of Q2 2026.
  • Journey Medical was a new Mercer Global Advisors position in Q2 2026.
  • Journey Medical made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5309 holding.
  • 43 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.